• Tenet Healthcare raised fiscal 2026 adjusted EBITDA guidance by $195 million to $5.05 billion-$5.2 billion.
• Adjusted free cash flow less noncontrolling interest distributions is forecast at $1.93 billion-$2.16 billion, a $100 million increase.
• The outlook projects revenue of $22.05 billion-$22.45 billion, with adjusted diluted earnings of $22.05-$23.01 per share.
• Third-quarter adjusted EBITDA rose 23.3% to $1.36 billion, including $147 million in favorable transition impacts.
• Contract transition activities are expected to contribute approximately $450 million to full-year adjusted EBITDA; those contributions are not expected to recur in 2027.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tenet Healthcare Corporation published the original content used to generate this news brief on October 29, 2026, and is solely responsible for the information contained therein.